Neuroimaging in neuropsychiatry

Psychiatric Clinics of North America

Volumn 28, Issue 3 SPEC. ISS., 2005, Pages 549-566

  Broderick, Daniel F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN TISSUE; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; DIAGNOSTIC PROCEDURE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MEDICAL RESEARCH; NEUROIMAGING; NEUROPSYCHIATRY; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PSYCHIATRIST; REVIEW; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRUCTURE ANALYSIS;

EID: 23944482508     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2005.05.007     Document Type: Review

References (48)

1. D. Weight, and E. Bigler Neuroimaging in psychiatry Psychiatr Clin North Am 21 4 1998 725 759
2. A. Gupta, M. Elheis, and K. Pansari Imaging in psychiatric illnesses Int J Clin Pract 58 9 2004 850 858
3. R. Parry, S. Glaze, and B. Archer Typical patient radiation doses in diagnostic radiology Radiographics 19 1999 1289 1302
4. F. Shellock, and J. Crues MR procedures: biologic effects, safety, and patient care Radiology 232 3 2004 635 652
5. A. Cwinn, and S. Grahovac Emergency CT scans of the head: a practical atlas 1998 Mosby-Year Book St. Louis (MO)
6. J. Sanders Computed tomography and magnetic resonance imaging W.W. Orrison Jr. Neuroimaging 1998 WB Saunders Philadelphia 12 36
7. K. Davis, D. Stewart, and J. Friedman White matter changes in schizophrenia Arch Gen Psychiatry 60 2003 443 456
8. C. Fennema-Notestine, S. Archibald, and M. Jacobson In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease Neurology 63 2004 989 995
9. M. Mascalchi, F. Lolli, and R. Della Nave Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain Neuroradiology 232 2004 867 873
10. C. Gaser, I. Nenadic, and B. Buchsbaum Ventricular enlargement in schizophrenia related to volume reduction of the thalamus, striatum, and superior temporal cortex Am J Psychiatry 161 1 2004 154 156
11. W. Byne, M. Buchsbaum, and E. Kemether Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder Arch Gen Psychiatry 58 2001 133 140
12. W. Taylor, E. Hsu, and K. Ranga Rama Krishnan Diffusion tensor imaging: background, potential, and utility in psychiatric research Biol Psychiatry 55 2004 201 207
13. P. Nestor, M. Kubicki, and R. Gurrera Neuropsychological correlates of diffusion tensor imaging in schizophrenia Neuropsychology 18 4 2004 629 637
14. B. Chong, J. Sanders, and G. Jones Functional magnetic resonance imaging W.W. Orrison Jr. Neuroimaging 1998 WB Saunders Philadelphia 60 86
15. C. Moritz, and V. Haughton Functional MR imaging: paradigms for clinical preoperative mapping Magn Reson Imaging Clin N Am 11 4 2003 529 542
16. G. Honey, and E. Bullmore Functional neuroimaging and schizophrenia Psychiatry 1 1 2002 26 29
17. P. Woodruff, I. Wright, and E. Bullmore Auditory hallucinations and the temporal cortical response to speech in schizophrenia: a functional magnetic resonance imaging study Am J Psychiatry 154 12 1997 1676 1682
18. Honey G, Bullmore E, Soni W, et al. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. PNAS 1999;96(23):13432-7.
19. B. Dickerson, D. Salat, and J. Bates Medial temporal lobe function and structure in mild cognitive impairment Ann Neurol 56 1 2004 7 9
20. T. Passe, H. Charles, and P. Rajagopalan Nuclear magnetic resonance spectroscopy: a review of neuropsychiatric applications Prog Neuropsychopharmacol Biol Psychiatry 19 4 1995 541 563
21. M. Castillo, L. Kwock, and S. Mukherji Clinical applications of proton MR spectroscopy AJNR Am J Neuroradiol 17 1996 1 15
22. B. Miller A review of chemical issues in 1H NMR spectroscopy: N-Acetyl-L-aspartate, creatine and coline NMR Biomed 4 1991 47 52
23. B. Miller, R. Moats, and T. Shonk Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy Radiology 187 2 1993 433 437
24. 1H MR spectroscopy Neuroradiology 215 2000 807 817
25. K. Lyoo, and P. Renshaw Magnetic resonance spectroscopy: current and future applications in psychiatric research Biol Psychiatry 51 2002 195 207
26. L. Chang, C. Cloak, and T. Ernst Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders J Clin Psychiatry 64 Suppl 3 2003 7 14
27. D. Chugangi, B. Sundram, and M. Behen Evidence of altered energy metabolism in autistic children Prog Neuropsychopharmacol Biol Psychiatry 23 1999 635 641
28. K. Abe, H. Terakawa, and M. Takanashi Proton magnetic resonance spectroscopy of patients with parkinsonism Brain Res Bull 52 6 2000 589 595
29. J. Stanley, P. Williamson, and D. Drost An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy Arch Gen Psychiatry 52 1995 399 406
30. 31P-MRS Biol Psychiatry 40 1996 785 793
31. M. Hartshorne Computed tomography and magnetic resonance imaging W.W. Orrison Jr. Neuroimaging 1998 WB Saunders Philadelphia 87 122
32. E. Rohren, T. Turkington, and R. Coleman Clinical applications of PET in oncology Radiology 231 2004 305 332
33. A. Newberg, A. Alavi, and M. Reivich Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disorders Semin Nucl Med 32 1 2002 13 34
34. R. Parsey, and J. Mann Applications of positron emission tomography in psychiatry Semin Nucl Med 33 2 2003 129 135
35. V. Kapoor, B. McCook, and F. Torok An introduction to PET-CT imaging Radiographics 24 2004 523 543
36. H. Schöder, W. Henry, D. Yeung, and M. Gonen Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion Radiology 231 2004 65 72
37. E. Hazlett, M. Buchsbaum, and E. Kemether Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia Am J Psychiatry 161 2004 305 314
38. E. Salmon, B. Sadzot, and P. Maquet Differential diagnosis of Alzheimer's disease with PET J Nucl Med 35 3 1994 391 398
39. R. Duara, W. Barker, and C.A. Luis Frontotemporal dementia and Alzheimer's disease. differential diagnosis Dement Geriatr Cogn Disord 10 Suppl 1 1999 37 42
40. I. Goto, T. Taniwaki, and S. Hosokawa Positron emission tomographic (PET) studies in dementia J Neurol Sci 114 1 1993 1 6
41. K. Shoghi-Jadid, G.W. Small, and E. Agdeppa Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer's disease Am J Geriatr Psychiatry 10 1 2002 24 35
42. L. Helmuth Long-awaited technique spots Alzheimer's toxin Science 297 5582 2002 752 753
43. S. Hesse, H. Barthel, and J. Schwarz Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders Neurosci and Biobehav Rev 28 2004 547 563
44. 11C](+)McN5652 Biol Psychiatry 51 2002 715 722
45. 11C](+)McN5652 shows increased serotonin transporter availability in major depression J Affect Disord 82 2004 321 327
46. R. Carne, T. O'Brien, and C. Kilpatrick MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome Brain 127 10 2004 2276 2285
47. B. Swartz, C. Brown, and M. Mandelkern The use of 2-deoxy-2-[18F]fluoro- D-glucose (FDG-PET) positron emission tomography in the routine diagnosis of epilepsy Mol Imaging Biol 4 3 2002 245 252
48. 18F-FDG PET imaging) Eur J Nucl Mol Imaging 32 2 2005 180 185